Prospeo
Hero Section BackgroundHero Section Background
Connect Biopharma

Connect Biopharma Email Formats

Biotechnology ResearchFlag of US3580 Carmel Mountain Road, Suite 200, United States21-50 Employees

Connect Biopharma Email Formats

Connect Biopharma uses 1 email format. The most common is {first name}{last name} (e.g., johndoe@connectbiopharma.com), used 100% of the time.

FormatExamplePercentage
{first name}{last name}
johndoe@connectbiopharma.com
100%

Key Contacts at Connect Biopharma

Flag of US

Janies Garcia

Director Of It

Flag of US

Surendra Chaturvedi

Sr. Director, Head Of Quality And Regulatory Cmc

Flag of CN

Jean Chen

风险与内控总监 Director Of Risk And Controls

Flag of US

Marissa Kinney

Associate Director Program Management

Flag of US

Barry Quart

Chief Executive Officer

Flag of US

Brandon Ngo

Senior Director Finance

Flag of US

Cindy J. Chen

Associate Director, Fp&A

Flag of US

Jelane Hart

Senior Director, Regulatory Affairs

Flag of CN

Shawn Yang

Director Of Discovery Department

Company overview

Headquarters3580 Carmel Mountain Road, Suite 200, San Diego, California 92130, US
Websites
NAICS541714
SIC283
Founded2012
Employees21-50
Socials

About Connect Biopharma

Connect Biopharma is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and COPD. Headquartered in San Diego, California, the Company is advancing rademikibart, a next-generation, potentially best-in-class antibody designed to target interleukin-4 receptor alpha (IL-4Rα). The Company is currently conducting global clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD, areas with significant unmet need. Connect also has an exclusive license and collaboration agreement for rademikibart with Simcere in China. Rademikibart is a fully human monoclonal antibody targeting IL-4Rα, a common subunit of interleukin-4 receptor (IL-4) and interleukin-13 receptor (IL-13). We believe that by binding with IL-4Rα, rademikibart can block the functions of IL-4 and IL-13 effectively, thereby blocking the T helper 2 (Th2) inflammatory pathway to achieving the goal of treating Th2 related inflammatory diseases such as atopic dermatitis and asthma. For more information visit www.connectbiopharma.com. The inclusion of forward-looking statements herein, including words such as "believe", should not be regarded as a representation by Connect Biopharma that any of its expectations, projections or plans will be achieved. Actual results may differ materially due to the risks and uncertainties inherent in our business and other risks described in our filings with the U.S. Securities and Exchange Commission (the “SEC”). Further information regarding these and other risks is included under the heading “Risk Factors” in our annual and periodic reports filed with the SEC. Connect Biopharma claims the protection of the safe harbor for forward-looking statements contained in the Act for all forward-looking statements, and undertakes no obligation to publicly update any forward-looking statements, whether because of new information, future events or otherwise, except as required by law.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Manager
Entry
Director

Employees by Department

Connect Biopharma has 24 employees across 9 departments.

Departments

Number of employees

Funding Data

Connect Biopharma has never raised funding before.

Frequently asked questions

Connect Biopharma is located in 3580 Carmel Mountain Road, Suite 200, US.
Connect Biopharma was founded in 2012, making it 14 years old. The company has established itself as a significant player in its industry over this time.
Connect Biopharma has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

4.8

40,000 users

top 50
high performer
most used
tier 1 accuracy

Build leads list with verified emails & mobiles